Reify Health

Reify Health is a clinical trial technology company focused on providing services via its two brands: 1) Care Access, for developing and setting up clinical trial sites, and 2) OneStudyTeam, for providing its online platform “StudyTeam” to manage patient recruitment initiatives.

The company claims that using StudyTeam can reduce the timeframe for patient enrollment by up to six weeks.

The platform also provides real-time feedback on patient recruitment failures, allowing clinical trials to amend protocols that are resulting in higher failure rates.

Key customers and partnerships

Some of the company’s research site partners include Circa, Corvallis Clinic, ECIR, East-West Medical, Intend Research, and Axiom.

As of June 2024, the company’s StudyTeam platform was available across 100+ countries and was being used by 7,000+ clinical sites to manage their patient recruitment process. It also noted that it was used by pharmaceutical companies such as Amgen, AstraZeneca, and Eli Lilly & Co.

Funding and financials

The company raised USD 220 million of Series D funding in April 2022, at a USD 4.8 billion valuation. The round was co-led by Altimeter Capital and Coatue, and was participated in by Dragoneer Group and ICONIQ Growth. The proceeds are to be used for improving patient diversity in clinical trials and for partner initiatives towards understanding challenges in under-penetrated demographics.